Sigurd Vitols

Publications
Public outreach and news

Articles

Article: VALUE IN HEALTH. 2023;26(5):639-648
Economic Evaluation of Elective Cesarean Section on Maternal Request Compared With Planned Vaginal Birth-Application to Swedish Setting Using National Registry Data
Berg J; Kallen K; Andolf E; Hellstrom-Westas L; Ekeus C; Alvan J; Vitols S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2022;78(9):1459-1467
Prevalence and initiation of statin therapy in the oldest old-a longitudinal population-based study
Sundvall H; Vitols S; Wallerstedt SM; Fastbom J
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(7):959-967
Use of statins in the elderly according to age and indicationa cross-sectional population-based register study
Sundvall H; Fastbom J; Wallerstedt SM; Vitols S
Article: JOURNAL OF RISK RESEARCH. 2019;22(6):796-802
Ruling out risks in medical research
Anttila S; Persson J; Rosen M; Vareman N; Vitols S; Sahlin N-E
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2017;90:59-67
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale
Welch VA; Akl EA; Guyatt G; Pottie K; Eslava-Schmalbach J; Ansari MT; de Beer H; Briel M; Dans T; Dans I; Hultcrantz M; Jull J; Katikireddi SV; Meerpohl J; Morton R; Mosdol A; Petkovic J; Schunemann HJ; Sharaf RN; Singh JA; Stanev R; Tonia T; Tristan M; Vitols S; Watine J; Tugwell P
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2017;90:76-83
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence
Welch VA; Ald EA; Pottie K; Ansari MT; Briel M; Christensen R; Dans A; Dans L; Eslava-Schmalbach J; Guyatt G; Hultcrantz M; Jull J; Katildreddi SV; Lang E; Matovinovic E; Meerpohl JJ; Morton RL; Mosdol A; Murad MH; Petkovic J; Schunemann H; Sharaf R; Shea B; Singh JA; Sola I; Stanev R; Stein A; Thabaneii L; Tonia T; Tristan M; Vitols S; Watine J; Tugwell P
Article: LIPIDS. 2017;52(6):523-534
Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms
Bhuiyan H; Masquelier M; Tatidis L; Gruber A; Paul C; Vitols S
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2017;26(1):9-16
Long-term use of proton pump inhibitors and prevalence of disease-and drug-related reasons for gastroprotection-a cross-sectional population-based study
Wallerstedt SM; Fastbom J; Linke J; Vitols S
Article: THERAPEUTIC DRUG MONITORING. 2016;38(2):239-245
Pronounced Interindividual But Not Intraindividual Variation in Tamoxifen and Metabolite Levels in Plasma During Adjuvant Treatment of Women With Early Breast Cancer
Fotoohi AK; Karim H; Lafolie P; Pohanka A; Ostervall J; Hatschek T; Vitols S
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013;437(2):280-286
Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Article: CURRENT DRUG DELIVERY. 2013;10(4):404-412
Comparison of Uptake Mechanisms for Anthracyclines in Human Leukemic Cells
Karim H; Bogason A; Bhuiyan H; Fotoohi AK; Lafolie P; Vitols S
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2011;71(4):514-521
Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia
Bogason A; Quartino AL; Lafolie P; Masquelier M; Karlsson MO; Paul C; Gruber A; Vitols S
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2011;108(4):224-233
The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
Gustafsson LL; Wettermark B; Godman B; Andersen-Karlsson E; Bergman U; Hasselstrom J; Hensjo L-O; Hjemdahl P; Jagre I; Julander M; Ringertz B; Schmidt D; Sjoberg S; Sjoqvist F; Stiller C-O; Tornqvist E; Tryselius R; Vitols S; von Bahr C
Article: DRUG METABOLISM LETTERS. 2010;4(4):228-232
Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia.
Bogason A; Masquelier M; Lafolie P; Skogastierna C; Paul C; Gruber A; Vitols S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2009;65(12):1179-1186
Uptake of anthracyclines in vitro and in vivo in acute myeloid leukemia cells in relation to apoptosis and clinical response
Bogason A; Bhuiyan H; Masquelier M; Paul C; Gruber A; Vitols S
Article: EPILEPSIA. 2008;49(6):1075-1080
Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy
Ohman I; Beck O; Vitols S; Tomson T
Article: PLOS ONE. 2008;3(11):e3771
ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes
Skogsberg J; Dicker A; Ryden M; Astrom G; Nilsson R; Bhuiyan H; Vitols S; Mairal A; Langin D; Alberts P; Walum E; Tegner J; Hamsten A; Arner P; Bjorkegren J
Article: LEUKEMIA RESEARCH. 2006;30(2):136-144
Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: Studies in human leukemic cells
Masquelier M; Lundberg B; Peterson C; Vitols S
Article: EPILEPSIA. 2005;46(10):1621-1624
Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation:: Does a fetal accumulation occur during pregnancy?
Öhman I; Vitols S; Tomson T
Article: LAKARTIDNINGEN. 2004;101(34):2573-2575
[It's possible to influence prescriptions patterns by producer-independent information].
Vitols S; Vetr A; Tomson T
Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(9):1639-1646
Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside
Masquelier M; Vitols S
Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(6):1047-1056
Relationship between daunorubicin concentration and apoptosis induction in leukemic cells
Masquelier M; Zhou QF; Gruber A; Vitols S
Article: EPILEPSIA. 2002;43(10):1157-1160
Topiramate kinetics during delivery, lactation, and in the neonate:: Preliminary observations
Öhman I; Vitols S; Luef G; Söderfeldt B; Tomson T
Article: BIOCHEMICAL PHARMACOLOGY. 2002;63(12):2169-2180
Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines
Tatidis L; Masquelier M; Vitols S
Article: LIPIDS. 2001;36(11):1233-1240
Growth modulation of low density lipoprotein receptor sterol sensitivity in cultured human fibroblasts
Tatidis L; Vitols S
Article: CANCER LETTERS. 2001;170(2):169-175
Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis
Tatidis L; Vitols S; Gruber A; Paul C; Axelson M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2001;56(11):843-848
Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners
Nilsson G; Hjemdahl P; Hässler A; Vitols S; Wallén NH; Krakau I
Article: EPILEPSIA. 2000;41(6):709-713
Lamotrigine in pregnancy: Pharmacokinetics during delivery, in the neonate, and during lactation
Ohman I; Vitols S; Tomson T
Article: JOURNAL OF DRUG TARGETING. 2000;8(3):155-164
Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy:: Study of stability of drug-carrier complexes in blood
Masquelier M; Vitols S; Pålsson M; Mårs U; Larsson BS; Peterson CO
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1999;105(2):420-427
Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL
Zhou R; Vitols S; Gruber A; Liliemark J; Wang Y; Liliemark E
Article: JOURNAL OF LIPID RESEARCH. 1998;39(2):423-436
Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro
Björkegren J; Karpe F; Vitols S; Tornvall P; Hamsten A
Article: JOURNAL OF LIPID RESEARCH. 1997;38(12):2436-2445
Decreased feedback regulation of low density lipoprotein receptor activity by sterols in leukemic cells from patients with acute myelogenous leukemia
Tatidis L; Gruber A; Vitols S
Article: EPILEPSIA. 1997;38(9):1039-1041
Lamotrigine in pregnancy and lactation: A case report
Tomson T; Ohman I; Vitols S
Article: LIPIDS. 1997;32(3):255-262
Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans - In vitro and in vivo studies
Vitols S; Angelin B; Juliusson GJ
Article: LAKARTIDNINGEN. 1997;94(6):444-445
[Individualize drug therapy!].
Vitols S
Article: BIOCHEMICAL PHARMACOLOGY. 1996;52(1):127-131
Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas
Vitols S; Gunven P; Gruber A; Larsson O
Article: JOURNAL OF INTERNAL MEDICINE. 1996;239(6):525-529
Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease
Kallner G; Vitols S; Ljunggren JG
Article: CANCER. 1995;76(3):423-428
DISEASE-RELATED HYPOCHOLESTEROLEMIA IN PATIENTS WITH HAIRY-CELL LEUKEMIA - POSITIVE CORRELATION WITH SPLEEN SIZE BUT NOT WITH TUMOR-CELL BURDEN OR LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVITY
JULIUSSON G; VITOLS S; LILIEMARK J
Article: LEUKEMIA AND LYMPHOMA. 1995;18(5-6):435-442
MULTIDRUG-RESISTANCE (MDR1) GENE-EXPRESSION IN PERIPHERAL BLASTS FROM PATIENTS WITH ACUTE-LEUKEMIA ONLY RARELY INCREASES DURING DISEASE PROGRESSION AFTER COMBINATION CHEMOTHERAPY
GRUBER A; ARESTROM I; ALBERTIONI F; BJORKHOLM M; PETERSON C
Article: THE BMJ. 1995;311(6996):27
MECHANISMS BEHIND HYPOCHOLESTEROLEMIA IN HAIRY-CELL LEUKEMIA
JULIUSSON G; VITOLS S; LILIEMARK J
Article: MEDICAL ONCOLOGY. 1995;12(2):79-86
MULTIDRUG-RESISTANCE GENE (MDR1) RNA LEVELS IN RELATION TO P-GLYCOPROTEIN CONTENT OF LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE-LEUKEMIA
ALBERTIONI F; GRUBER A; ARESTROM I; VITOLS S
Show more

All other publications

Review: JOURNAL OF ORAL REHABILITATION. 2017;44(10):800-826
Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta-analysis
Haggman-Henrikson B; Alstergren P; Davidson T; Hogestatt ED; Ostlund P; Tranaeus S; Vitols S; List T
Review: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2016;72(10):1161-1169
Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies-a systematic review
Arnlind MH; Fryklund L; Vitols S; Bertilsson G
Review: BREAST. 2016;26:106-114
Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials
Ryden L; Arnlind MH; Vitols S; Hoistad M; Ahlgren J
Letter: LAKARTIDNINGEN. 2013;110(5):227
[More randomized studies in health care can be made cheaper and more regularly].
Rosén M; Adolfsson J; Liliemark J; Vitols S
Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2004;94(3):106-111
The choice of proton pump inhibitor:: Does it matter?
Hellström PM; Vitols S
Review: LAKARTIDNINGEN. 2003;100(25):2212-2216
[All proton pump inhibitors are equally efficacious in standard dosages].
Hellström PM; Vitols S
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2003;253(2):95-98
Paracetamol hepatotoxicity at therapeutic doses
Vitols S
Letter: THE BMJ. 2001;322(7278):111
Orlistat associated with hypertension - Reply
Persson M; Vitols S; Yue QY
Letter: THE BMJ. 2000;321(7253):87
Drug points - Orlistat associated with hypertension
Persson M; Vitols S; Yue QY
Letter: JOURNAL OF LIPID RESEARCH. 1996;37(10):2266-2267
Untitled
Rudling M; Masquelier M; Vitols S; Peterson C
Letter: THE BMJ. 1995;311(7017):1437-1438
HYPOCHOLESTEROLEMIA IN HAIRY-CELL LEUKEMIA - REPLY
JULIUSSON G; VITOLS S

Articles

All other publications

News from KI

Events from KI